Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Ibadete BytyciGani BajraktariPeter E PensonMichael Y HeneinMaciej Banachnull nullnull nullPublished in: British journal of clinical pharmacology (2021)
Colchicine reduced CV events and inflammatory markers, high-sensitivity C-reactive protein and IL-6, in patients with coronary disease compared to controls. Its impact on cardiovascular and all-cause mortality requires further investigation.